欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1545/002
药品名称
Pantoprazol Aurovitas
活性成分
pantoprazole sodium sesquihydrate 45.11 mg
剂型
Gastro-resistant tablet
上市许可持有人
Aurovitas, Unipessoal, Lda
参考成员国 - 产品名称
Portugal (PT)
Pantoprazol Aurovitas
互认成员国 - 产品名称
Belgium (BE)
Pantoprazol Aurobindo 40 mg maagsapresistente tabletten
Spain (ES)
许可日期
2016/09/21
最近更新日期
2024/02/01
药物ATC编码
A02BC02 pantoprazole
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
1545_Pantoprazol_Ritisca_Summary_PAR_Scientific_Final11ABR2017
Date of last change:2024/09/06
Final PL
|
common_pl_40mg_clean
Date of last change:2024/09/06
Final SPC
|
common_spc_40mg_clean
Date of last change:2024/09/06
Final Product Information
|
DCP_Pantoprazole Ritisca 20 mg _SPC
Date of last change:2024/09/06
Final Product Information
|
DCP_Pantoprazole Ritisca 20 mg_LAB
Date of last change:2024/09/06
Final Product Information
|
DCP_Pantoprazole Ritisca 20 mg_PIL
Date of last change:2024/09/06
Final Product Information
|
DCP_Pantoprazole Ritisca 40 mg _SPC
Date of last change:2024/09/06
Final Product Information
|
DCP_Pantoprazole Ritisca 40 mg_LAB
Date of last change:2024/09/06
Final Product Information
|
DCP_Pantoprazole Ritisca 40 mg_PIL
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase